Stephens initiated coverage of Arvinas (ARVN) with an Overweight rating and $55 price target. The firm is adding to its Biotechnology research coverage with a focus on targeted protein degradation, or ...

When five-year-old golden doodle, Lucy, was diagnosed with T-cell lymphoma, owners Stéphanie Gauvin and Tim MacIsaac knew ...

Donald Trump is considering recess appointments to skip over Senate confirmations for some of the most powerful positions in ...

Biden Allows Ukraine to Strike Russia With Long-Range U.S. Missiles President Biden for the first time authorized the use of a system known as ATACMS to help defend Ukraine’s forces in the Kursk ...